Please login to the form below

Not currently logged in
Email:
Password:

Quintiles' Dennis Gillings steps down as CEO

Pharma services company appoints Accenture man Tom Pike as replacement

Quintiles CEO Tom PikePharma services company Quintiles has appointed former Accenture executive Tom Pike as its new CEO and he joins on April 30 to take the helm from current CEO Dennis Gillings.

Gillings, who founded Quintiles in 1982, is not departing the company altogether, and will stay on as executive chairman of its board of directors.

Quintiles said the move was part of its long-term succession planning and Gillings praised Pike's “impressive track record of helping customers navigate fast-changing environments”.

“Tom has a disciplined and forthright approach that will enable him to earn the trust of customers and employees alike,” Gillings said.

“I'm confident he will soon make his mark on our company and the industry at large, continuing the Quintiles tradition of entrepreneurial leadership and pioneering growth.”

Pike joins the company after spending two years working with health and technology start-ups, but for the 22 years before that he served at management consultancy Accenture.

There his roles included leading the North America health and products business areas and serving as global chief operating officer for Accenture's Resources operating group.

Pike said: “Healthcare is the most important industry of the next quarter century, and I'm excited because Quintiles is right at the centre of improving the health of millions of people around the world.

“It's extremely motivating to join the company at this point in time. I understand the magnitude and complexity of its customers' challenges. I'm looking forward to bringing my skills and experience to help this talented team build on its successes as it continues its journey as one of the world's great companies.”

24th April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics